other material
confidence high
sentiment neutral
materiality 0.30
Sunshine Biopharma reduces Series B warrant exercise price to $1.2202 after ATM sales
Sunshine Biopharma Inc.
- Exercise price of Series B warrants reduced to $1.2202 due to recent common stock sales under ATM offering.
- Adjustment triggered by anti-dilution provisions in the warrant terms.
- Further adjustments may occur as set forth in the Series B warrant agreement.